Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma

Anaplastic thyroid carcinoma (ATC) is a deadly disease with very limited therapeutic options. There is an urgent need for new and efficacious drugs. Unfortunately accrual in clinical trials is problematic because of the rarity of the disease and often poor performance status at diagnosis. Recently s...

Descripción completa

Detalles Bibliográficos
Autores principales: Spalart, Valérie, Legius, Barbara, Segers, Kurt, Coolen, Johan, Maes, Brigitte, Decoster, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899289/
https://www.ncbi.nlm.nih.gov/pubmed/31885948
http://dx.doi.org/10.1155/2019/9095753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899289/
https://www.ncbi.nlm.nih.gov/pubmed/31885948
http://dx.doi.org/10.1155/2019/9095753

Ejemplares similares